Has Wesley Moore, MD received payments from drug or device companies?

Yes. Drug and device makers reported $31,578 in general payments to Wesley Moore, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wesley Moore, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wesley Moore, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wesley Moore, MD

Vascular Surgery · Los Angeles, CANPI 1053335133

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $24,200 of the $31,578 with a category attached, or 76.6%. Silk Road Medical, Inc. accounts for 91.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $16,879 and has fallen 97.0% since, to $506 in 2025.

$31,578in general payments, 2019–2025

Across 66 payments — averaging $478.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Silk Road Medical, Inc.$29K
W. L. Gore & Associates, Inc.$1K
Medtronic$610
Cook Medical LLC$208
Abbott$166
Smith+Nephew$124
plus $259 from 4 others

$20,340in research payments, 2019–2025

Across 4 payments — averaging $5085.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Silk Road Medical, Inc.$20K

What the payments were for

Consulting fees$24,20077%
Travel & lodging$3,17910%
Food & beverage$4,19913%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Silk Road Medical, Inc.	40	$28,854
W. L. Gore & Associates, Inc.	11	$1,356
Medtronic	6	$610
Cook Medical LLC	3	$208
Abbott	1	$166
Smith+Nephew	1	$124
Endologix LLC	1	$103
Penumbra, Inc.	1	$78
Baxter Healthcare	1	$58
Inspiremd Ltd	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENROUTE Transcarotid Neuroprotection System$32,566
ENROUTE Transcarotid Stent System$15,941
ENHANCE Transcarotid Peripheral Access Kit$15,941
ENROUTE 0.014 Guidewire$15,941
ENROUTE Transcarotid Stent$12,194
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$4,431
ENDURANT IIS$421
GORE EXCLUDER AAA Endoprosthesis$278
GORE TAG Thoracic Branch Endoprosthesis$191
GORE VIABAHN VBX Balloon Expandable Endo$187
EXCLUDER Iliac Branch Endoprosthesis$167
PERCLOSE PROGLIDE$166
EXCLUDER Conformable AAA Endoprosthesis with Active Control$155
Stravix$124
GrafixPL$124
Cook Medical Aortic Intervention$103
ENDOCROSS Device$103
Torus Stent Graft System$103

How this compares

$31,578 in reported general payments places this provider in the 85th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024

$26,211

Medicare patients

169

Services billed

227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ezetimibe	66	$2,974
Atorvastatin Calcium	69	$1,031
Rosuvastatin Calcium	26	$628
ClopidogrelClopidogrel Bisulfate	20	$219
Lovastatin	11	$18

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Los Angeles

Sukgu HanLos Angeles$477K
Johnathon RolloLos Angeles$337K
Gregory MageeLos Angeles$152K
Rajeev RaoLos Angeles$107K
Juan JimenezLos Angeles$91K
Miguel ManzurLos Angeles$88K
Bernardo Curi MendesLos Angeles$76K
William Quinones-BaldrichLos Angeles$53K
Sharon KiangLos Angeles$46K
Fred WeaverLos Angeles$42K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →